CA
BSX icon

Crewe Advisors’s Boston Scientific BSX Stock Holding History

Crewe Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.3K Buy
663
+184
+38% +$9.99K ﹤0.01% 537
2026
Q1 		$30.1K Buy
479
+59
+14% +$4.72K ﹤0.01% 440
2025
Q4 		$40K Buy
420
+51
+14% +$5K ﹤0.01% 393
2025
Q3 		$36K Buy
369
+205
+125% +$21.2K ﹤0.01% 411
2025
Q2 		$17.6K Sell
164
-39
-19% -$3.95K ﹤0.01% 389
2025
Q1 		$20.5K Buy
203
+55
+37% +$5.54K ﹤0.01% 349
2024
Q4 		$13.2K Buy
148
+36
+32% +$3.17K ﹤0.01% 403
2024
Q3 		$9.39K Buy
112
+18
+19% +$1.42K ﹤0.01% 504
2024
Q2 		$7.24K Sell
94
-148
-61% -$10.8K ﹤0.01% 738
2024
Q1 		$16.6K Buy
+242
New +$15.6K ﹤0.01% 520
2023
Q4 		– Sell
-7
Closed -$370 – 452
2023
Q3 		$370 Hold
7
– – ﹤0.01% 407
2023
Q2 		$379 Sell
7
-422
-98% -$22K ﹤0.01% 656
2023
Q1 		$21.5K Sell
429
-134
-24% -$6.32K ﹤0.01% 418
2022
Q4 		$26.1K Sell
563
-301
-35% -$13K ﹤0.01% 379
2022
Q3 		$33K Buy
864
+141
+20% +$5.66K 0.01% 371
2022
Q2 		$27K Buy
+723
New +$29.4K 0.01% 368
2020
Q4 		– Sell
-65
Closed -$2K – 472
2020
Q3 		$2K Buy
+65
New +$2.5K ﹤0.01% 479
2020
Q1 		– Sell
-73
Closed -$3K – 187
2019
Q4 		$3K Buy
+73
New +$3.06K ﹤0.01% 211

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Crewe Advisors's BSX Position: Q2 2026 in Review

Crewe Advisors increased its Boston Scientific (BSX) stake by 38% in Q2 2026, buying an estimated $9.99K and bringing the position to 663 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Crewe Advisors first reported a position in BSX in Q4 2019 and has held it in 18 quarters since. The position peaked at $40K in Q4 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Crewe Advisors held 663 shares of Boston Scientific worth $28.3K as of Q2 2026.
  • Crewe Advisors bought 184 Boston Scientific shares in Q2 2026, an estimated $9.99K.
  • Boston Scientific made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #537 holding.
  • Crewe Advisors first reported a position in Boston Scientific in Q4 2019 and has held it in 18 quarters since.
  • Crewe Advisors's Boston Scientific position peaked at $40K in Q4 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.